Literature DB >> 16287149

Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung.

Alan B Shafer1.   

Abstract

Four separate metaanalyses of factor analyses were conducted for the Beck Depression Inventory (BDI), the Center for Epidemiological Studies Depression Scale (CES-D), the Hamilton Rating Scale for Depression (HRSD), and the Zung Self-Rating Depression Scale (SDS). The total number of participants (N) and studies (k) included in each of the metaanalyses were the following: BDI (N = 13,643, k = 33), CES-D (N = 22,340, k = 28), HRSD (N = 2,606, k = 17), and SDS (N = 12,621, k = 13). Metaanalysis results suggest that the specific depression symptom factors within each test appear to be relatively robust and well established and match fairly closely previously hypothesized factor structures. A general Depression Severity factor and a small Somatic Symptoms factor are found in all four tests and two tests had a small Positive Affect factor. There were fewer common specific depression symptom factors across tests than expected.

Entities:  

Mesh:

Year:  2006        PMID: 16287149     DOI: 10.1002/jclp.20213

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  240 in total

1.  Reinvention of depression instruments by primary care clinicians.

Authors:  Seong-Yi Baik; Junius J Gonzales; Barbara J Bowers; Jean S Anthony; Bas Tidjani; Jeffrey L Susman
Journal:  Ann Fam Med       Date:  2010 May-Jun       Impact factor: 5.166

2.  Gender differences in the relationship between affect and adolescent smoking uptake.

Authors:  Janet Audrain-McGovern; Daniel Rodriguez; Adam M Leventhal
Journal:  Addiction       Date:  2015-01-05       Impact factor: 6.526

Review 3.  Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.

Authors:  Adam M Leventhal; Michael J Zvolensky
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

4.  Where is the pleasure in that? Low hedonic capacity predicts smoking onset and escalation.

Authors:  Janet Audrain-McGovern; Daniel Rodriguez; Adam M Leventhal; Jocelyn Cuevas; Kelli Rodgers; Joseph Sass
Journal:  Nicotine Tob Res       Date:  2012-03-01       Impact factor: 4.244

5.  Depression is more than the sum score of its parts: individual DSM symptoms have different risk factors.

Authors:  E I Fried; R M Nesse; K Zivin; C Guille; S Sen
Journal:  Psychol Med       Date:  2013-12-02       Impact factor: 7.723

6.  Problematic substance use among Hispanic adolescents and young adults: implications for prevention efforts.

Authors:  Timothy J Halley Grigsby; Myriam Forster; Daniel Wood Soto; Lourdes Baezconde-Garbanati; Jennifer Beth Unger
Journal:  Subst Use Misuse       Date:  2014-06       Impact factor: 2.164

7.  Dimensions in major depressive disorder and their relevance for treatment outcome.

Authors:  Elske Vrieze; Koen Demyttenaere; Ronny Bruffaerts; Dirk Hermans; Diego A Pizzagalli; Pascal Sienaert; Titia Hompes; Peter de Boer; Mark Schmidt; Stephan Claes
Journal:  J Affect Disord       Date:  2013-10-19       Impact factor: 4.839

8.  Depressive symptoms are associated with allostatic load among community-dwelling older adults.

Authors:  Roni W Kobrosly; Edwin van Wijngaarden; Christopher L Seplaki; Deborah A Cory-Slechta; Jan Moynihan
Journal:  Physiol Behav       Date:  2014-01-17

9.  Treating co-occurring depression and anxiety: modeling the dynamics of psychopathology and psychotherapy using the time-varying effect model.

Authors:  Aidan G C Wright; Michael N Hallquist; Holly A Swartz; Ellen Frank; Jill M Cyranowski
Journal:  J Consult Clin Psychol       Date:  2013-09-16

10.  Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence.

Authors:  Emma E M Knowles; Samuel R Mathias; Godfrey D Pearlson; Jennifer Barrett; Josephine Mollon; Dominique Denbow; Katrina Aberzik; Molly Zatony; David C Glahn
Journal:  Schizophr Res       Date:  2018-10-26       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.